NCT00859300View on ClinicalTrials.gov

MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction

CompletedOBSERVATIONAL
Enrollment

1,011

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Myocardial Infarction
Interventions
GENETIC

Blood sample

Blood sample Determination of genetic background

GENETIC

Blood sample

Blood sample Determination of genetic background

Trial Locations (1)

69677

Hôpital cardiologique, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT00859300 - MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction | Biotech Hunter | Biotech Hunter